The University of Southampton
University of Southampton Institutional Repository

Cooperation between MDM2 and MDMX in the regulation of p53

Cooperation between MDM2 and MDMX in the regulation of p53
Cooperation between MDM2 and MDMX in the regulation of p53
Murine double minute-2 (MDM2) was first described as a p53-associated protein and potential oncogene in the early 1990s. Its paralogue MDMX was subsequently identified in a screen for p53-binding proteins. Extensive evidence now confirms both proteins to be oncogenic in both mice and humans, largely through their ability to negatively regulate the tumour-suppressor activities of p53. It is now clear that the two proteins form heterodimers, and act in concert to regulate p53 activity in proliferating and stressed cells. In this chapter I firstly review the several mechanisms whereby MDM2 and MDMX are potentially able to regulate p53 function independently of each other. I then examine how heterodimerisation between the two molecules influences how they regulate the abundance and activity of both p53, and each other. I conclude by examining current models of how the dynamic equilibrium between p53 and its two negative regulators is maintained in proliferating cells, and is targeted by multiple signalling pathways to control the magnitude and duration of the p53-dependent transcriptional response to genotoxic stress.
978-1-4419-8230-8
83-97
Landes Bioscience
Blaydes, Jeremy
e957f999-fd91-4f77-ad62-5b4ef069b15b
Hupp, T.R.
Ayed, A.
Blaydes, Jeremy
e957f999-fd91-4f77-ad62-5b4ef069b15b
Hupp, T.R.
Ayed, A.

Blaydes, Jeremy (2010) Cooperation between MDM2 and MDMX in the regulation of p53. In, Hupp, T.R. and Ayed, A. (eds.) p53. Austin, USA. Landes Bioscience, pp. 83-97.

Record type: Book Section

Abstract

Murine double minute-2 (MDM2) was first described as a p53-associated protein and potential oncogene in the early 1990s. Its paralogue MDMX was subsequently identified in a screen for p53-binding proteins. Extensive evidence now confirms both proteins to be oncogenic in both mice and humans, largely through their ability to negatively regulate the tumour-suppressor activities of p53. It is now clear that the two proteins form heterodimers, and act in concert to regulate p53 activity in proliferating and stressed cells. In this chapter I firstly review the several mechanisms whereby MDM2 and MDMX are potentially able to regulate p53 function independently of each other. I then examine how heterodimerisation between the two molecules influences how they regulate the abundance and activity of both p53, and each other. I conclude by examining current models of how the dynamic equilibrium between p53 and its two negative regulators is maintained in proliferating cells, and is targeted by multiple signalling pathways to control the magnitude and duration of the p53-dependent transcriptional response to genotoxic stress.

This record has no associated files available for download.

More information

Published date: 2010

Identifiers

Local EPrints ID: 66670
URI: http://eprints.soton.ac.uk/id/eprint/66670
ISBN: 978-1-4419-8230-8
PURE UUID: dc0e79e8-dc34-4b62-b127-3c2a68fcd9bc
ORCID for Jeremy Blaydes: ORCID iD orcid.org/0000-0001-8525-0209

Catalogue record

Date deposited: 08 Jul 2009
Last modified: 23 Jul 2022 01:47

Export record

Contributors

Author: Jeremy Blaydes ORCID iD
Editor: T.R. Hupp
Editor: A. Ayed

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×